Zenas BioPharma, Inc. (ZBIO)
NASDAQ: ZBIO · Real-Time Price · USD
10.10
+0.12 (1.20%)
Apr 25, 2025, 9:30 AM EDT - Market open
Zenas BioPharma Employees
Zenas BioPharma had 130 employees as of December 31, 2024.
Employees
130
Change
n/a
Growth
n/a
Revenue / Employee
$38,462
Profits / Employee
-$1,207,600
Market Cap
422.17M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 130 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ZBIO News
- 3 days ago - Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors to Act Following Significant Post-IPO Losses - GlobeNewsWire
- 4 days ago - Zenas Biopharma Investors Urged to Contact Cohen Milstein After Post-IPO Losses - GlobeNewsWire
- 7 days ago - Gainey McKenna & Egleston Announces A Class Action Lawsuit Has Been Filed Against Zenas BioPharma, Inc. (ZBIO) - GlobeNewsWire
- 7 days ago - Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 17 days ago - Zenas: Differentiated B-Cell Targeting Drug With Q3 Of 2025 Catalyst - Seeking Alpha
- 18 days ago - Zenas BioPharma Appoints Haley Laken, Ph.D., as Chief Scientific Officer - GlobeNewsWire
- 5 weeks ago - Zenas BioPharma Gains Outperform Rating From Analyst As Key Autoimmune Trials Progress - Benzinga
- 5 weeks ago - Zenas BioPharma Appoints Lisa von Moltke, M.D., as Head of Research and Development and Chief Medical Officer - GlobeNewsWire